Evaluation and Optimization of the Clinical Accuracy of Hybribio's 14 High-Risk HPV with 16/18 Genotyping Assay within the VALGENT-3 Framework [Virology]
In conclusion, HBRT-H14 was as sensitive but less specific than HC2 for detecting cervical precancer at the predefined cutoff. However, HBRT-H14 fulfilled international accuracy criteria for cervical cancer screening when using an optimized cutoff and might be attractive in low-resource settings given its low cost.
Source: Journal of Clinical Microbiology - Category: Microbiology Authors: Xu, L., Ostrbenk Valencak, A., Poljak, M., Arbyn, M. Tags: Virology Source Type: research
More News: Cancer | Cancer & Oncology | Cervical Cancer | China Health | Cytology | Genital Warts | HPV Testing | Human Papillomavirus (HPV) | Microbiology | Slovenia Health | Study | Virology